RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-9.4%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.68B
AUM Growth
+$1.68B
(-9.9%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
74.63%
Holding
34
New
9
Increased
4
Reduced
5
Closed
2
Top Buys
| 1 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$70.3M |
| 2 |
Travere Therapeutics
TVTX
|
$46.2M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$33.2M |
| 4 |
Solid Biosciences
SLDB
|
$19.5M |
| 5 |
Kodiak Sciences
KOD
|
$14.7M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$58.5M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$28.3M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$14.8M |
| 4 |
Axsome Therapeutics
AXSM
|
$13.7M |
| 5 |
X4 Pharmaceuticals
XFOR
|
$4.87M |
Sector Composition
| 1 | Healthcare | 97.05% |
| 2 | Technology | 0.16% |
